[Skip to Navigation]
Sign In
Views 529
Citations 0
Correction
August 16, 2021

Errors in Results and Table 1

JAMA Neurol. 2021;78(10):1278. doi:10.1001/jamaneurol.2021.2833

The Original Investigation titled “Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: a Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials,”1 published online August 19, 2019, had errors in the Results and Table 1. The number of patients who had a new stroke (ischemic or hemorrhagic) receiving aspirin alone at 90 days should be 459. In addition, the 95% CI for the adjusted hazard ratio for the association of clopidogrel-aspirin and total hemorrhage (major or minor hemorrhage) should be 1.39 to 2.54. This article was corrected online.

References
1.
Pan  Y, Elm  JJ, Li  H,  et al.  Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials.   JAMA Neurol. 2019;76(12):1466-1473. doi:10.1001/jamaneurol.2019.2531PubMedGoogle Scholar
×